Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Lemaitre Vascular (LMAT) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Lemaitre Vascular (LMAT) over the last 16 years, with Q3 2025 value amounting to 33.27%.

  • Lemaitre Vascular's EBITDA Margin rose 92900.0% to 33.27% in Q3 2025 from the same period last year, while for Sep 2025 it was 25.71%, marking a year-over-year increase of 24300.0%. This contributed to the annual value of 23.77% for FY2024, which is 47900.0% up from last year.
  • Lemaitre Vascular's EBITDA Margin amounted to 33.27% in Q3 2025, which was up 92900.0% from 25.13% recorded in Q2 2025.
  • Lemaitre Vascular's 5-year EBITDA Margin high stood at 33.27% for Q3 2025, and its period low was 13.74% during Q2 2022.
  • Moreover, its 5-year median value for EBITDA Margin was 21.09% (2025), whereas its average is 21.63%.
  • Per our database at Business Quant, Lemaitre Vascular's EBITDA Margin tumbled by -135700bps in 2022 and then skyrocketed by 92900bps in 2025.
  • Lemaitre Vascular's EBITDA Margin (Quarter) stood at 21.01% in 2021, then decreased by -19bps to 17.01% in 2022, then rose by 23bps to 20.88% in 2023, then increased by 10bps to 23.07% in 2024, then skyrocketed by 44bps to 33.27% in 2025.
  • Its EBITDA Margin was 33.27% in Q3 2025, compared to 25.13% in Q2 2025 and 21.09% in Q1 2025.